Montreal, Quebec, January 16, 2007 – LMS Medical Systems Inc. (the “Company”) (AMEX:LMZ; TSX:LMZ) wishes to clarify the press release disseminated by the Company on January 12, 2007. That press release announced that on January 8, 2007, the Company received notice (the “Notice”) from the American Stock Exchange (the “AMEX”) staff. The Notice indicated that the Company is below certain of the AMEX’s continued listing standards due to shareholder’s equity being less than $4,000,000 and losses from continuing operations and/or net losses in three out of its four most recent fiscal years, and shareholder’s equity being less than $6,000,000 and losses from continuing operations and/or net losses in its five most recent fiscal years as set forth in Sections 1003(a)(ii) and 1003(a)(iii), respectively, of the AMEX Company Guide (the “Company Guide”).

The Company was afforded the opportunity to submit a plan of compliance to the AMEX by February 8, 2007 that demonstrates that the Company’s ability to regain compliance with Sections 1003(a)(ii) and 1003(a)(iii) of the Company Guide by July 8, 2008. If the Company does not submit a plan or if the plan is not accepted by the AMEX, the Company will be subject to delisting procedures set forth in Section 1010 and Part 12 of the Company Guide.

The Company plans on submitting the Plan on or before February 8, 2007.

About LMS:

LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM™ Suite provides physicians, nursing staff, risk managers and hospital administrators with clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.

For further information please contact: